Genfit - ADR

NASDAQ:GNFT   12:52:12 AM EDT
3.79
0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)188.72M
Current PE125.23
Forward PE 5.57
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$33.63 Million
Adjusted EPS$0.11
See more estimates
10-Day MA$3.77
50-Day MA$4.10
200-Day MA$4.18
See more pivots

Genfit - ADR Stock, NASDAQ:GNFT

Parc Eurasante, 885, Avenue Eug��ne Avin�©e, Loos, Hauts-de-France 59120
France
Phone: +33.3.20.16.40.00
Number of Employees: 159
http://www.genfit.com

Description

Genfit SA is a biopharmaceutical company involved in drug discovery and development for the early diagnosis, prevention and treatment of cardiometabolic diseases. The company focuses on the discovery and development of drug candidates in areas of high unmet medical needs corresponding to a lack of suitable treatments. It focuses on medicines to market for patients with metabolic, inflammatory, autoimmune and fibrotic diseases that affect the liver. The company was founded by Jean-Fran�§ois Mouney, Florence S�©journ�©, and Bart Staels in September 1999 and is headquartered in Loos, France.